Meet the team

Professor Lovat was a scholar at the City of London School. He qualified from University College Hospital Medical School having also gained a first class honours degree in nutrition. He received a prestigious MRC research fellowship to fund his PhD studies at the Royal Postgraduate Medical School.

He then trained in advanced therapeutic endoscopy at University College London Hospitals and was appointed a Consultant Gastroenterologist & Senior Lecturer in 1999. He was appointed as the first Head of the newly established Research Department for Tissue and Energy at UCL and was awarded his professorship in 2014 based on the quality of his research into complications of acid reflux disease and minimally invasive treatment to prevent and treat oesophageal cancer.

In 2017 he became the clinical director of the WEISS Centre at UCL which brings clinicians and medical engineers together to solve some of the most complex technical problems in medical intervention. As part of this work, he has led multiple studies on artificial intelligence in endoscopy which have resulted in CE marked devices which are now being rolled out across hospitals around the world.

He has been appointed to numerous national and international bodies:

• 2000 – 2 Member, Committee, British Oesophago-Gastric Cancer Group (BASO)
• 2002 – 5 Member, Oesophageal Section Committee, British Society of Gastroenterology
• 2002 – 5 Member, Research Committee, British Society of Gastroenterology
• 2002 – 4 Member, Fundraising Committee, Barrett’s Oesophagus Foundation
• 2002 – Member, Scientific Advisory Group, UK Barrett’s Oesophagus Registry
• 2003 – Member, UK National PDT Advisory Board
• 2004 – Convenor and advisory board, PROBE (Patient Research Network for Oesophageal Cancer and Barrett’s Epithelium)
• 2005 – Member, Scientific Advisory Committee, Barrett’s Oesophagus Foundation
• 2006 – Topic Lead, Barrett’s Oesophagus, National Electronic Library for Health, Gastroenterology & Liver Diseases Specialist Library
• 2006 – 7 Member, Evaluation Board, Gastroenterology & Hepatology Faculty, Faculty of 1000 Medicine
• 2005 – 8 Member, Committee, Imaging and Advanced Technology Section, American Gastroenterology Association
• 2005 – 8 Specialist Advisor to NICE’s Interventional Procedures Programme.
• 2009 – 10 Member, NICE Guideline Development Group for Ablative Therapy in Barrett’s Oesophagus
• 2015- Member, Biobank Ethical Research Committee, UCL/UCLH Biobank for studying health and disease2
• 2015- Medical Advisory Board, Heartburn Cancer UK
• 2019- Patron, Heartburn Cancer UK
• 2017-19 Board Member, UCLH BRC Clinical Research Informatics Unit (CRIU)
• 2019- Medical Advisor: Odin Vision Ltd

2022

1. Bagchi, B., Salvadores Fernandez, C., Bhatti, M., Ciric, L., Lovat, L., & Tiwari, M. K. Copper nanowire embedded hypromellose: An antibacterial nanocomposite film. Journal of Colloid and Interface Science. 608(1), 30-39. 2022 Feb 15. doi:10.1016/j.jcis.2021.09.130.
2. Hussein M, González-Bueno Puyal J, Lines D, et al, Lovat LB,. A new artificial intelligence system successfully detects and localises early neoplasia in Barrett’s esophagus by using convolutional neural networks. United Eur Gastroenterol J. 2022;10(6):528-537. doi:10.1002/ueg2.12233
3. Partridge T, Massimi L, Wolfson P, Lovat LB, et al. Intra-operative assessment of cancer with x-ray phase contrast computed tomography. Proceedings of SPIE 2022;(October):46. doi:10.1117/12.2632294
4. Wolfson P, Ho KMA, Wilson A, et al, Lovat LB. Endoscopic eradication therapy for Barrett’s esophagus–related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry. Gastrointest Endosc. 2022;96(2):223-233. doi:10.1016/j.gie.2022.02.016
5. Kader R, Baggaley RF, Hussein M, et al, Lovat LB. Survey on the perceptions of UK gastroenterologists and endoscopists to artificial intelligence. Frontline Gastroenterology 2022;(1):1-7. doi:10.1136/flgastro-2021-101994
6. Maity AK, Stone TC, Ward V, Lovat LB, et al. Novel epigenetic network biomarkers for early detection of esophageal cancer. Clin Epigenetics. Published online 2022:1-14. doi:10.1186/s13148-022-01243-5
7. Chadebecq F, Lovat LB, Stoyanov D. Artificial intelligence and automation in endoscopy and surgery. Nat Rev Gastroenterol Hepatol. Published online November 9, 2022. doi:10.1038/S41575-022-00701-Y

2021

1. Ho KMA, Baggaley RF, Stone T, et al, Lovat LB. Face mask acceptability for communal religious worship during the COVID-19 pandemic: results from the CONFESS study. J Relig Health. 2021;60(0123456789):under review. doi:10.1007/s10943-022-01641-2
2. Kader, R., Hadjinicolaou, A., Georgiades, F., Stoyanov, D., & Lovat, L. B. Optical diagnosis of colorectal polyps using convolutional neural networks. World Journal of Gastroenterology. 27(35), 12 pages. 2021 Sep 21. doi:10.3748/wjg.v27.i35.5908.
3. Wolfson, P., Ho, K. M. A., Bassett, P., Haidry, R., Olivo, A., Lovat, L., & Sami, S. S. Accuracy of clinical staging for T2N0 oesophageal cancer: systematic review and meta-analysis. Diseases of the Esophagus. 34(8), 12 pages. 2021 Aug 10. doi:10.1093/dote/doab002.
4. Ahmad OF, González-Bueno Puyal J, Brandao P, et al, Lovat LB,. Performance of artificial intelligence for detection of subtle and advanced colorectal neoplasia. Dig Endosc. Published online 2021. doi:10.1111/DEN.14187

12. Hussein M., Sehgal V., Sami S., Bassett P., Sweis R., Graham D., Telese A., Morris D., Rodriguez-Justo M., Jansen M., Novelli M., Banks M., Lovat L.B, Haidry R. The natural history of low-grade dysplasia in Barrett’s esophagus and risk factors for progression. JGH Open: An Open Access Journal of Gastroenterology and Hepatology. 5(9), 1019-1025. 2021 Aug 6. doi: 10.1002/jgh3.12625.

13. Ococks E, Sharma S, Tian Ng AW, Aleshin A, Fitzgerald RC, Smyth E; OCCAMS Consortium, Fitzgerald RC, Edwards PAW, Grehan N, Nutzinger B, Fidziukiewicz E, Redmond AM, Northrop A, Abbas S, Smyth EC, O’Donovan M, Miremadi A, Malhotra S, Tripathi M, Grantham A, Cheah C, Coles H, Flint C, Eldridge M, Secrier M, Devonshire G, Jammula S, Davies J, Crichton C, Carroll N, Hardwick RH, Safranek P, Hindmarsh A, Sujendran V, Hayes SJ, Ang Y, Sharrocks A, Preston SR, Bagwan I, Save V, Skipworth RJE, Hupp TR, O’Neill JR, Tucker O, Beggs A, Taniere P, Puig S, Contino G, Underwood TJ, Walker RC, Grace BL, Lagergren J, Gossage J, Davies A, Chang F, Mahadeva U, Goh V, Ciccarelli FD, Sanders G, Berrisford R, Chan D, Cheong E, Kumar B, Sreedharan L, Parsons SL, Soomro I, Kaye P, Saunders J, Lovat L, Haidry R, Scott M, Sothi S, Lishman S, Hanna GB, Peters CJ, Moorthy K, Grabowska A, Turkington R, McManus D, Coleman H, Petty RD. Serial ctDNA detection using a personalized, tumor-informed assay in esophageal adenocarcinoma patients following resection. 2021 Jul 17. S0016-5085(21)03245-5. doi: 10.1053/j.gastro.2021.07.011. Online ahead of print.

14. Ho KM, Davies H, Epstein R, Bassett P, Hogan A, Kabir Y, Rubin J, Shin GY, Reid J, Torii R, Tiwari M, Balachandran R, Lovat LB. Spatiotemporal droplet dispersion measurements demonstrate face masks reduce risks from singing: results from the COvid aNd FacEmaSkS Study (CONFESS). medRxiv. 2021 Jul 14. doi: 10.1101/2021.07.09.21260247

15. Wong, YT; Tayeb, MA; Stone, TC; Lovat, LB; Teschendorff, AE; Iwasiow, R; Craig, JM; (2021) A comparison of epithelial cell content of oral samples estimated using cytology and DNA methylation. 8 pages. 2021 Jul 13. doi: 10.1080/15592294.2021.1950977. Online ahead of print.

16. Hussein M, Alzoubaidi D, O’Donnell M, de la Serna A, Bassett P, Varbobitis I, Hengehold T, Ortiz Fernandez-Sordo J, Rey JW, Hayee B, Despott EJ, Murino A, Graham D, Latorre M, Moreea S, Boger P, Dunn J, Mainie I, Mullady D, Early D, Ragunath K, Anderson J, Bhandari P, Goetz M, Kiesslich R, Coron E, Rodriguez de Santiago E, Gonda T, Gross SA, Lovat LB, Haidry R. Hemostatic powder TC-325 treatment of malignancy-related upper gastrointestinal bleeds: International registry outcomes. Journal of Gastroenterology and Hepatology. 6 pages. 2021 Jun 28. doi: 10.1111/jgh.15579. Epub ahead of print. PMID: 34132412.

17. Telese, A., Sehgal, V., Magee, C.G., Naik, S., Alqahtani, S.A., Lovat, L.B. & Haidry, R.J. Bariatric and Metabolic Endoscopy: A New Paradigm. Clinical and Translational Gastroenterology. 12 (6). 2021 Jun 18. doi: 10.14309/ctg.0000000000000364.

18. Ho, K. M. A., Banerjee, A., Lawler, M., Rutter, M. D., & Lovat, L. Predicting endoscopic activity recovery in England after COVID-19: a national analysis. Lancet Gastroenterol Hepatol. 6(5): 381–390. 2021 May. doi:10.1016/S2468-1253(21)00058-3.
19. Humm, G., Harries, R. L., Stoyanov, D., & Lovat, L. B. Supporting laparoscopic general surgery training with digital technology: The United Kingdom and Ireland paradigm. BMC Surg, 21 (1), 123. 2021 Mar 8. doi:10.1186/s12893-021-01123-4.

20. Eluri S, Paterson A, Lauren BN, O’Donovan M, Bhandari P, di Pietro M, Lee M, Haidry R, Lovat L, Ragunath K, Hur C, Fitzgerald RC, Shaheen NJ. Utility and cost-effectiveness of a non-endoscopic approach to Barrett’s esophagus surveillance after endoscopic therapy. Clinical Gastroenterology and Hepatology. 2021 Feb 10. doi:10.1016/j.cgh.2021.02.013. Online ahead of print.

21. Magee CG, Graham D, Gordon C, Dunn J, Penman I, Willert R, Smart H, Ortiz-Fernandez-Sordo J, Ragunath K, Everson M, Alzoubaidi D, Banks M, Morris D, Sami S, Morris AJ, Bhandari P, Narayanasamy R, Di Pietro M, Lovat LB, Haidry R. Radiofrequency ablation for Barrett’s oesophagus related neoplasia with the 360 Express catheter: initial experience from the United Kingdom and Ireland—preliminary results. Surgical Endoscopy. 2021 Feb 5. doi:10.1007/s00464-021-08325-0. Online ahead of print.

22. Everson MA, Herrera LCGP, Wang H-P, Lee C-T, Chung C-S, Hsieh P-H, Chen C-C, Tseng C-H, Hsu M-H, Vercauteren T, Ourselin S, Kashin S, Bisschops R, Pech O, Lovat L, Wang W-L, Haidry RJ. A clinically interpretable convolutional neural network for the real time prediction of early squamous cell cancer of the esophagus; comparing diagnostic performance with a panel of expert European and Asian endoscopists. Gastrointest Endosc. 94(2), 273-281. 2021 Feb 4. doi:10.1016/j.gie.2021.01.043.

2020

23. Berkel, N. V., Ahmad, O. F., Stoyanov, D., Lovat, L., & Blandford, A. Designing Visual Markers for Continuous Artificial Intelligence Support. ACM Transactions on Computing for Healthcare. 2020 Dec;2(1):1-24. doi:10.1145/3422156.

24. Bekker L-G, Delany-Moretlwe S, Biccard B, duToit L, Lovat LB, Dehbi H-M, Moonesinghe R, Rees H, Avidan MS. Protecting healthcare workers: A critical part of the COVID-19 response. SAMJ South African Medical Journal. 2020 Dec;110(12):1154-1155. doi:10.7196/SAMJ.2020.v110i12.15048.

25. Hussein M, Alzoubaidi D, Serna A, Weaver M, Fernandez-Sordo JO, Rey JW, Hayee B, Despott E, Murino A, Moreea S, Boger P, Dunn J, Mainie I, Graham D, Mullady D, Early D, Ragunath K, Anderson J, Bhandari P, Goetz M, Kiesslich R, Coron E, de Santiago ER, Gonda T, Lovat LB, Haidry R. Outcomes of Hemospray therapy in the treatment of intraprocedural upper gastrointestinal bleeding post-endoscopic therapy. United European Gastroenterol J. 2020 Dec;8(10):1155-1162. doi: 10.1177/2050640620938549.

26. Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Li Y, Kelso S, Akbani R, Anur P, Bailey MH, Buchanan A, Chiotti K, PCAWG Consortium. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nat Commun. 2020 Nov;11(1):6232. https://doi.org/10.1038/s41467-020-20128-w.

27. Ho KMA, Anandhakrishnan A, Mahay A, Soo Y, Lovat LB, Rochford AP. How COVID-19 has changed the unselected medical take: an observational study. Clin Med (Lond). 2020 Nov;20(6):e229-e233. doi: 10.7861/clinmed.2020-0483.

28. Ahmad OF, Mori Y, Misawa M, Kudo SE, Anderson JT, Bernal J, Berzin TM, Bisschops R, Byrne MF, Chen PJ, East JE, Eelbode T, Elson DS, Gurudu SR, Histace A, Karnes WE, Repici A, Singh R, Valdastri P, Wallace MB, Wang P, Stoyanov D, Lovat LB. Establishing key research questions for the implementation of artificial intelligence in colonoscopy: a modified Delphi method. 2020 Nov 9. doi: 10.1055/a-1306-7590. Epub ahead of print.

29. Hussein M, González-Bueno Puyal J, Mountney P, Lovat LB, Haidry R. Role of artificial intelligence in the diagnosis of oesophageal neoplasia: 2020 an endoscopic odyssey. World Journal of Gastroenterology. 2020 Oct;26(38):5784-5796. doi:10.3748/wjg.v26.i38.5784.

30. Ohrenstein, D. C., Brandao, P., Toth, D., Lovat, L., Stoyanov, D., & Mountney, P. Detecting small polyps using a Dynamic SSD-GAN. arXiv. 2020 Oct;2010:15937.

31. Puyal JGB, Bhatia KK, Brandao P, Ahmad OF, Toth D, Kader R, Lovat L, Mountney P, Stoyanov D. Endoscopic Polyp Segmentation Using a Hybrid 2D/3D CNN. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics).2020 Sep;12266:295-305. doi:10.1007/978-3-030-59725-2_29.

32. Dvir O., Wolfson P., Lovat L., Moskovitch R. Falls Prediction in Care Homes Using Mobile App Data Collection. In: Michalowski M., Moskovitch R. (eds). Artificial Intelligence in Medicine. AIME. Lecture Notes in Computer Science. 2020 Sep;12299(1):403-413. Springer, Cham. https://doi.org/10.1007/978-3-030-59137-3_36.

33. Lipman G, Markar S, Gupta A; UK RFA Registry Working Group, Haidry RJ, Lovat LB. Learning curves and the influence of procedural volume for the treatment of dysplastic Barrett’s esophagus. Gastrointestinal Endoscopy. 2020 Sep;92(3):543-550.e1. doi: 10.1016/j.gie.2020.02.041.

34. Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Kelso S, Akbani R, Anur P, Bailey MH, Buchanan A, Chiotti K, Covington K, Creason A, Ding L, Ellrott K, Fan Y, Foltz S, Getz G, Hale W, Haussler D, Hess JM, Hutter CM, Kandoth C, Kasaian K, Kasapi M, Larson D, Leshchiner I, Letaw J, Ma S, McLellan MD, Men Y, Mills GB, Niu B, Peto M, Radenbaugh A, Reynolds SM, Saksena G, Sofia H, Stewart C, Struck AJ, Stuart JM, Wang W, Weinstein JN, Wheeler DA, Wong CK, Xi L, Ye K, Bailey MH, Niu B, Bieg M, Boutros PC, Buchhalter I, Butler AP, Chen K, Chong Z, Ding L, Drechsel O, Jonathan Dursi L, Eils R, Espiritu SMG, Fan Y, Fulton RS, Gao S, Gelpi JLL, Gerstein MB, Getz G, Gonzalez S, Gut IG, Hach F, Heinold MC, Hess JM, Hinton J, Hu T, Huang V, Huang Y, Hutter B, Jones DR, Jung J, Jäger N, Kim HL, Kleinheinz K, Kumar S, Kumar Y, Lalansingh CM, Letunic I, Livitz D, Ma EZ, Maruvka YE, Mashl RJ, McLellan MD, Menzies A, Milovanovic A, Nielsen MM, Ossowski S, Paramasivam N., PCAWG Consortium. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nature Communications. 2020 Sep;11(1):4748. doi:10.1038/s41467-020-18151-y.

35. Fitzgerald RC, di Pietro M, O’Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, Gehrung M, Offman J, Tripathi M, Smith SG, Aigret B, on behalf of the BEST3 Trial team. Cytosponge-trefoil factor 3 versus usual care to identify Barrett’s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. The Lancet. 2020 Aug;396(10247):333-344. doi:10.1016/S0140-6736(20)31099-0.

36. Li CH, Prokopec SD, Sun RX, Yousif F, Schmitz N, Al-Shahrour F, Atwal G, Bailey PJ, Biankin AV, Boutros PC, Campbell PJ, Chang DK, Cooke SL, Deshpande V, Faltas BM, Faquin WC, Garraway L, Getz G, Grimmond SM, Haider S, Hoadley KA, Jiao W, Kaiser VB, Karlić R, Kato M, Kübler K, Lazar AJ, PCAWG Consortium. Sex differences in oncogenic mutational processes. Nature Communications. 2020 Aug;11(1):4330. doi:10.1038/s41467-020-17359-2

37. Alzoubaidi D, Hussein M, Sehgal V, Makahamadze C, Magee CG, Everson M, Graham D, Sweis R, Banks M, Sami SS, Novelli M, Lovat L, Haidry R. Cryoballoon ablation for treatment of patients with refractory esophageal neoplasia after first line endoscopic eradication therapy. Endosc Int Open. 2020 Jul;8(7):E891-E899. doi: 10.1055/a-1149-1414.

38. He Q, Bano S, Ahmad OF, Yang B, Chen X, Valdastri P, Lovat LB, Stoyanov D, Zuo S. Deep learning-based anatomical site classification for upper gastrointestinal endoscopy. Int J Comput Assist Radiol Surg. 2020 Jul;15(7):1085-1094. doi: 10.1007/s11548-020-02148-5.

39. Knight WRC, McEwen R, Byrne BE, Habib W, Bott R, Zylstra J, Mahadeva U, Gossage JA, Fitzgerald RC, Noorani A, Edwards PAW, Grehan N, Nutzinger B, Hughes C, Fidziukiewicz E, MacRae S, Northrop A, Contino G, Li X, de la Rue R, Katz-Summercorn A, Abbas S, Loureda D, O’Donovan M, Miremadi A, Malhotra S, Tripathi M, Tavaré S, Lynch AG, Eldridge M, Secrier M, Devonshire G, Perner J, Jammula S, Davies J, Crichton C, Carroll N, Safranek P, Hindmarsh A, Sujendran V, Hayes SJ, Ang Y, Sharrocks A, Preston SR, Oakes S, Bagwan I, Save V, Skipworth RJE, Hupp TR, O’Neill JR, Tucker O, Beggs A, Taniere P, Puig S, Underwood TJ, Walker RC, Grace BL, Barr H, Shepherd N, Old O, Lagergren J, Davies A, Chang F, Goh V, Ciccarelli FD, Sanders G, Berrisford R, Harden C, Lewis M, Cheong E, Kumar B, Parsons SL, Soomro I, Kaye P, Saunders J, Lovat L, Haidry R, Igali L, Scott M, Sothi S, Suortamo S, Lishman S, Hanna GB, Moorthy K, Peters CJ, Grabowska A, Turkington R, McManus D, Coleman H, Khoo D, Fickling W. Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagus. European Journal of Surgical Oncology. 2020 Jul;46(12):2257-2261. doi:10.1016/j.ejso.2020.07.003.

2019

1. Rau, A., Edwards, P. J. E., Ahmad, O. F., Riordan, P., Janatka, M., Lovat, L. B., & Stoyanov, D. (2019). Implicit domain adaptation with conditional generative adversarial networks for depth prediction in endoscopy.. Int J Comput Assist Radiol Surg. doi:10.1007/s11548-019-01962-w
2. Everson, M., Magee, C., Alzoubaidi, D., Brogden, S., Graham, D., Lovat, L. B., . . . Haidry, R. (2019). Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett’s Esophagus-Related Neoplasia: A Feasibility Study. Digestive Diseases and Sciences. doi:10.1007/s10620-019-05607-5
3. Sanagapalli, S., Roman, S., Hastier, A., Leong, R. W., Patel, K., Raeburn, A., . . . Sweis, R. (2019). Achalasia diagnosed despite normal integrated relaxation pressure responds favorably to therapy. Neurogastroenterology & Motility. doi:10.1111/nmo.13586
4. Peerally, M. F., Bhandari, P., Ragunath, K., Barr, H., Haidry, R., Lovat, L., . . . de Caestecker, J. S. (2019). Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett’s esophagus: a randomized pilot study (BRIDE). Gastrointest Endosc. doi:10.1016/j.gie.2018.07.031
5. Ahmad, O. F., Stoyanov, D., & Lovat, L. B. (2019). Human-machine collaboration: Bringing artificial intelligence into colonoscopy. Frontline Gastroenterology. doi:10.1136/flgastro-2018-101047
6. Frankell, A. M., Jammula, S. G., Li, X., Contino, G., Killcoyne, S., Abbas, S., . . . Kumar, B. (2019). The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic. Nature Genetics, 51, 506-516. doi:10.1038/s41588-018-0331-5
7. Alzoubaidi, D., Graham, D., Bassett, P., Magee, C., Everson, M., Banks, M., . . . Haidry, R. (2019). Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett’s esophagus-related neoplasia.. Surg Endosc. doi:10.1007/s00464-018-06655-0
8. Garcia, E., Hayden, A., Birts, C., Britton, E., Rogerson, C., Bleaney, C. W., . . . Tavare, S. (2019). Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1 (vol 6, 32417, 2016). SCIENTIFIC REPORTS, 9, 5 pages. doi:10.1038/s41598-018-37591-7
9. Everson, M., Herrera, L. C. G. P., Li, W., Luengo, I. M., Ahmad, O., Banks, M., Magee, C., Alzoubaidi, D., Hsu, HM., Graham, D., Vercauteren, T., Lovat. L,. Ourselin, S., Kashin, S., Hsiu-Po Wang, Wen-Lun Wang, Haidry, R. J. (2019). Artificial intelligence for the real-time classification of intrapapillary capillary loop patterns in the endoscopic diagnosis of early oesophageal squamous cell carcinoma: A proof-of-concept study. United European Gastroenterology Journal. doi:10.1177/2050640618821800
10. Magee, C., Lipman, G., Alzoubaidi, D., Everson, M., Sweis, R., Banks, M., Graham, D., Gordon, C., Lovat, L., Murray, C., & Haidry, R. (2019). Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia. United European Gastroenterology Journal. doi:10.1177/2050640618814659
11. Ahmad OF, Soares AS, Mazomenos E, Brandao P, Vega R, Seward E, Stoyanov D, Chand M, Lovat LB (2019). Artificial intelligence and computer-aided diagnosis in colonoscopy: current evidence and future directions. The Lancet Gastroenterology and Hepatology, 4 (1), 71-80. doi:10.1016/S2468-1253(18)30282-6

2018

1. Garcia-Peraza-Herrera LC, Everson M, Li W, Luengo I, Berger L, Ahmad O, Lovat L, Wang H-P, Wang W-L, Haidry R, Stoyanov D, Vercauteren T, Ourselin S (2018). Interpretable Fully Convolutional Classification of Intrapapillary Capillary Loops for Real-Time Detection of Early Squamous Neoplasia. arXiv.
2. Sehgal, V., Rosenfeld, A., Graham, D. G., Lipman, G., Bisschops, R., Ragunath, K., . . . Lovat, L. B. (2018). Machine Learning Creates a Simple Endoscopic Classification System that Improves Dysplasia Detection in Barrett’s Oesophagus amongst Non-expert Endoscopists. GASTROENTEROLOGY RESEARCH AND PRACTICE, ARTN 1872437. doi:10.1155/2018/1872437
3. Peerally, M. F., Bhandari, P., Ragunath, K., Barr, H., Haidry, R., Lovat, L., . . . de Caestecker, J. S. (2018). Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or T1 adenocarcinoma in Barrett’s esophagus: a randomized pilot study (BRIDE). Gastrointest Endosc. doi:10.1016/j.gie.2018.07.031
4. Schiff ER, Frampton M, Ben-Yosef N, Avila BE, Semplici F, Pontikos N, Bloom SL, McCartney SA, Vega R, Lovat LB, Wood E, Hart A, Israeli E, Crespi D, Furman MA, Mann S, Murray CD, Segal AW, Levine AP (2018). Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease. Human Genetics. doi:10.1007/s00439-018-1927-7
5. Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R (2018). Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol, 24 (41), 4698-4707. doi:10.3748/wjg.v24.i41.4698
6. Chand, M., Ramachandran, N., Stoyanov, D., & Lovat, L. (2018). Robotics, artificial intelligence and distributed ledgers in surgery: data is key!. Tech Coloproctol. doi:10.1007/s10151-018-1847-5
7. Everson, M. A., Lovat, L. B., Graham, D. G., Bassett, P., Magee, C., Alzoubaidi, D., . . . Haidry, R. J. (2018). Virtual chromoendoscopy using optical enhancement improves the detection of Barrett’s esophagus-associated neoplasia. Gastrointest Endosc. doi:10.1016/j.gie.2018.09.032
8. Pollit V, Graham D, Leonard C, Filby A, McMaster J, Mealing SJ, Lovat LB, Haidry RJ (2018). A cost-effectiveness analysis of endoscopic eradication therapy (EET) for management of dysplasia arising in patients with Barrett’s esophagus in the United Kingdom. Curr Med Res Opin, 1-29. doi:10.1080/03007995.2018.1552407
9. Schiff ER, Frampton M, Semplici F, Bloom SL, McCartney SA, Vega R, Lovat LB, WOOD E, HART AL, Crespi D, Furman MA, Mann S, Murray CD, Segal AW, Levine AP (2018). A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population. Digestive Diseases and Sciences. doi:10.1007/s10620-018-5219-9
10. Sawas T, Killcoyne S, Iyer PG, Wang KK, Smyrk TC, Kisiel JB, Qin Y, Ahlquist DA, Rustgi AK, Costa RJ, Gerstung M, Fitzgerald RC, Katzka DA, Noorani A, Edwards PAW, Grehan N, Nutzinger B, Hughes C, Fidziukiewicz E, Bornschein J, MacRae S, Crawte J, Contino G, Li X, Rue RDL, O’Donovan M, Miremad A, Malhotra S, Tripathi M, Tavaré S, Lynch AG, Eldridge M, Secrier M, Bower L, Devonshire G, Perner J, Jammula S, Davies J, Crichton C, Carroll N, Safranek P, Hindmarsh A, Sujendran V, Hayes SJ, Ang Y, Preston SR, Oakes S, Bagwan I, Save V, Skipworth RJE, Hupp TR, O’Neill JR, Tucker O, Beggs A, Taniere P, Puig S, Underwood TJ, Noble F, Owsley J, Barr H, Shepherd N, Old O, Lagergren J, Gossage J, Davies A, Chang F, Zylstra J, Mahadeva U, Goh V, Ciccarelli FD, Sanders G, Berrisford R, Harden C, Bunting D, Lewis M, Cheong E, Kumar B, Parsons SL, Soomro I, Kaye P, Saunders J, Lovat L, Haidry R, Eneh V, Igali L, Scott M, Sothi S, Suortamo S, Lishman S, Hanna GB, Peters CJ, Grabowska A, Turkington R (2018). Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts. Gastroenterology, 155 (6), 1720-1728.e4. doi:10.1053/j.gastro.2018.08.036
11. Walter, D., van den Berg, M. W., Hirdes, M. M., Vleggaar, F. P., Repici, A., Deprez, P. H., Viedma, B. L., Lovat, L. B., Weusten, B. L., Bisschops, R., Haidry, R., Ferrara, E., Sanborn, K. J., O’leary, E. E., van Hooft, J. E., Siersema, P. D. (2018). Dilation or biodegradable stent placement for recurrent benign esophageal strictures: a randomized controlled trial.. Endoscopy. doi:1055/a-0602-4169
12. Pye, H., Butt, M. A., Funnell, L., Reinert, H. W., Puccio, I., Khan, S. U. R., . . . Lovat, L. B. (2018). Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression. Oncotarget, 9(33), 22945-22959. doi:18632/oncotarget.25159
13. Zheng, S. C., Webster, A. P., Dong, D., Feber, A., Graham, D. G., Sullivan, R., Jevons, S., Lovat, L.B., Beck, S., Widschwendter, M., Teschendorff, A. E. (2018). A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix.. Epigenomics. doi:2217/epi-2018-0037
14. Cotton, C. C., Haidry, R., Thrift, A. P., Lovat, L., & Shaheen, N. J. (2018). Development of Evidence Based Surveillance Intervals following Radiofrequency Ablation of Barrett’s Esophagus.. Gastroenterology. doi:1053/j.gastro.2018.04.011
15. Sanagapalli, S., Emmanuel, A., Leong, R., Kerr, S., Lovat, L., Haidry, R., . . . Sweis, R. (2018). Impaired motility in Barrett’s esophagus: A study using high-resolution manometry with physiologic challenge.. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. doi:1111/nmo.13330
16. Everson, M. A., Ragunath, K., Bhandari, P., Lovat, L., & Haidry, R. (2018). How to perform a high-quality examination in patients with Barrett’s oesophagus. Gastroenterology. doi:1053/j.gastro.2018.03.001
17. Puccio, I., Khan, S., Butt, A., Graham, D., Sehgal, V., Patel, D., … Lovat LB . Hamoudi, R. A. (2018). Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence. International Journal of Experimental Pathology. doi:1111/iep.12260

2017

22. Noble, F., Lloyd, M. A., Turkington, R., Griffiths, E., O’Donovan, M., O’Neill, J. R., Lovat, L., . . Tavaré, S. (2017). Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma. British Journal of Surgery, 104(13), 1816-1828. doi:1002/bjs.10627
23. Kohoutova, D., Haidry, R., Banks, M., Butt, M. A., Dunn, J., Thorpe, S., & Lovat, L. (2017). Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett’s oesophagus related neoplasia. Scandinavian Journal of Gastroenterology, 1-6. doi:1080/00365521.2017.1403646
24. Britton, J., Gadeke, L., Lovat, L., Hamdy, S., Hawkey, C., McLaughlin, J., & Ang, Y. (2017). Research priority setting in Barrett’s oesophagus and gastro-oesophageal reflux disease.. The Lancet. Gastroenterology & Hepatology. doi:1016/s2468-1253(17)30250-9
25. Lipman, G., Bisschops, R., Sehgal, V., Ortiz-Fernández-Sordo, J., Sweis, R., Esteban, J. M., Hamoudi, R., Banks, M. R., Lovat, L. B., Haidry, R. J. (2017). Systematic assessment with I-SCAN magnification endoscopy and acetic acid improves dysplasia detection in patients with Barrett’s esophagus.. Endoscopy. doi:1055/s-0043-113441
26. Noorani, A., Bornschein, J., Lynch, A. G., Secrier, M., Achilleos, A., Eldridge, M., . . . Fitzgerald, R. C. (2017). A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy. Genome research, 27 (6), 902-912. doi:10.1101/gr.214296.116
27. Filby, A., Taylor, M., Lipman, G., Lovat, L., & Haidry, R. (2017). Cost-effectiveness analysis of endoscopic eradication therapy for treatment of high-grade dysplasia in Barrett’s esophagus. Journal of comparative effectiveness research. doi:10.2217/cer-2016-0089
28. Ross-Innes CS, Chettouh H, Achilleos A, Galeano-Dalmau N, Debiram-Beecham I, MacRae S, Fessas P, Walker E, Varghese S, Evan T, Lao-Sirieix PS, O’Donovan M, Malhotra S, Novelli M, Disep B, Kaye PV, Lovat LB, Haidry R, Griffin M, Ragunath K, Bhandari P, Haycock A, Morris D, Attwood S, Dhar A, Rees C, Rutter MD, Ostler R, Aigret B, Sasieni PD, Fitzgerald RC. (2017). Risk stratification of Barrett’s oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. The Lancet Gastroenterology and Hepatology, 2 (1), 23-31. doi:10.1016/S2468-1253(16)30118-2
29. Butt, M. A., Pye, H., Haidry, R., Oukrif, D., Khan, S., Puccio, I., . . . Lovat, L. (2017). Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate. Oncotarget. doi:10.18632/oncotarget.15340
30. Pye H. Butt M.A. Reinert H.W. Maruani A. Nunes J.P.M. Marklew J.S. Qurashi M. Funnell L. May A. Stamati I. Hamoudi R. Baker J.R. Smith M.E.B. Caddick S. Deonarain M.P. Yahioglu G. Chudasama V. Lovat L.B. 2016. A HER2 selective theranostic agent for surgical resection guidance and photodynamic therapy. Photobiol. Sci. DOI: 10.1039/c6pp00139d.

2016

1. Di Caro S, Cheung WH, Fini L, Keane MG, Theis B, Haidry R, Di Renzo L, De Lorenzo A, Lovat L, Batterham RL, Banks M (2016). Role of body composition and metabolic profile in Barrett’s oesophagus and progression to cancer. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 28 (3), 251-260. doi:10.1097/MEG.0000000000000536
2. M. Secrier, X. Li, N. de Silva, M. D. Eldridge, G. Contino, J. Bornschein, S. MacRae, N. Grehan, M. O’Donovan, A. Miremadi, T.-P. Yang, L. Bower, H. Chettouh, J. Crawte, N. Galeano-Dalmau, A. Grabowska, J. Saunders, T. Underwood, N. Waddell, A. P. Barbour, B. Nutzinger, A. Achilleos, P. A. W. Edwards, A. G. Lynch, S. Tavaré, R. C. Fitzgerald, A. Noorani, R. F. Elliott, J. Weaver, C. Ross-Innes, L. Smith, Z. Abdullahi, R. de la Rue, A. Cluroe, S. Malhotra, R. Hardwick, H. Ford, M. L. Smith, J. Davies, R. Turkington, S. J. Hayes, Y. Ang, S. R. Preston, S. Oakes, I. Bagwan, V. Save, R. J. E. Skipworth, T. R. Hupp, J. R. O’Neill, O. Tucker, P. Taniere, F. Noble, J. Owsley, L. Lovat, R. Haidry, V. Eneh, C. Crichton, H. Barr, N. Shepherd, O. Old, J. Lagergren, J. Gossage, A. Davies, F. Chang, J. Zylstra, G. Sanders, R. Berrisford, C. Harden, D. Bunting, M. Lewis, E. Cheong, B. Kumar, S. L. Parsons, I. Soomro, P. Kaye, P. Collier, L. Igali, I. Welch, M. Scott, S. Sothi, S. Suortamo, S. Lishman, D. Beardsmore, H. E. Francies, M. J. Garnett, J. V Pearson, K. Nones, A.-M. Patch, and S. M. Grimmond, Sep. 2016.  Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance. Nature Genetics, 48 (10), 1131-1141. doi:10.1038/ng.3659
3. Markar SR, Mackenzie H, Ni M, Huddy JR, Askari A, Faiz O, Griffin SM, Lovat L, Hanna GB (2016). The influence of procedural volume and proficiency gain on mortality from upper GI endoscopic mucosal resection. Gut. doi:10.1136/gutjnl-2015-311237
4. Di Caro S. Cheung W.H. Fini L. Keane M.G. Theis B. Haidry R. Di Renzo L. De Lorenzo A. Lovat L. Batterham R.L. Banks M. 2016. Role of body composition and metabolic pro fi le in Barrett ’ s oesophagus and progression to cancer. Eur. J. Gasteroenterology Hepatol. 28 251–260.
5. Levine A.P. Pontikos N. Schiff E.R. Jostins L. Speed D. NIDDK Inflammatory Bowel Disease Genetics Consortium. Lovat L.B. Barrett J.C. Grasberger H. Plagnol V. Segal A.W. 2016. Genetic Complexity of Crohn’s Disease in Two Large Ashkenazi Jewish Families. Gasteroenterology 1–12. DOI: http://dx.doi.org/10.1053/j.gastro.2016.06.040

2015

1. Rosenfeld A. Graham D.G. Hamoudi R. Butawan R. Eneh V. Khan S. Miah H. Niranjan M. Lovat L.B. MIAT: A Novel Attribute Selection Approach to Better Predict Upper Gastrointestinal Cancer. IEEE2015: 36678: 1-7
2. Ross-Innes C.S. Becq J. Warren A. Cheetham R.K. Northen H. Donovan M.O. Malhotra S. Pietro M. Ivakhno S. He M. Weaver J.M.J. Lynch A.G. Kingsbury Z. Ross M. Humphray S. Bentley D. Fitzgerald R.C. Yeng A. Lydon A-M. Dharmaprasad S. Greer S. Preston S. Oakes S. Save V. Paterson-Brown S. Tucker O. Alderson D. Taniere P. Kelly J. Byrne J. Sharland D. Holling N. Boulter L. Noble F. Stacey B. Crichton C. Barr H. Shepherd N. Almond LM. Old O. Lagergren J. Gossage J. Davies A. Mason R. Chang F. Zylstra J. Sanders G. Wheatley T. Berrisford R. Bracey T. Harden C. Bunting D. Roques T. Nobes J. Loo S. Lewis M. Cheong E. Priest O. Parsons SL. Soomro I. Kaye P. Saunders J. Pang V. Welch NT. Catton JA. Duffy JP. Ragunath K. Lovat L. Haidry R. Miah H. Kerr S. Eneh V. Butawan R. Igali L. Ford H. Gilligan D. Safranek P. Hindmarsh A. Sudjendran V. Metz A. Carroll N. Scott M. Cluroe A. Miremadi A. Mahler-Araujo B. Knight O. Nutzinger B. Peters C. Abdullahi Z. Debriram-Beecham I. Malhotra S. Crawte J. MacRae S. Noorani A. Elliott RF. Li X. Bower L. Achilleos A. Bornschein J. Zeki S. Chettouh H. Secrier M. de Silva N. Gregson E. Yang T-P. O’Neil JR. 2015. Whole-genome sequencing provides new insights into the clonal architecture of Barrett ’s esophagus and esophageal adenocarcinoma. Nat. Genet. 47 1038–1046.
3. Haidry R.J. Lipman G. Banks M.R. Butt M.A. Sehgal V. Graham D. Dunn J.M. Gupta A. Sweis R. Miah H. Morris D. Smart H.L. Bhandari P. Willert R. Fullarton G. Morris J. Pietro M. Di Gordon C. Penman I. Barr H. Patel P. Boger P. Kapoor N. Mahon B. Hoare J. Narayanasamy R. Cheong E. Direkze N.C. Ang Y. Veitch A. Dhar A. Nyalender D. Ragunath K. Leahy A. Fullard M. Rodriguez-Justo M. Novelli M. Lovat L.B.  2015. Comparing outcome of radiofrequency ablation in Barrett ’ s with high grade dysplasia and intramucosal carcinoma : a prospective multicenter UK registry. Endoscopy 47 980–987.
4. De Sordi L. Butt M.A. Pye H. Kohoutova D. Mosse C.A. Yahioglu G. Stamati I. Deonarain M. Battah S. Ready D. Allan E. Mullany P. Lovat L.B.. Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficile. PLoS One 2015:10: 1–17.
5. Kohoutova D. Haidry R. Banks M. Bown S. Butt M.A. Graham D. Thorpe S. Novelli M. Rodriguez-justo M. Lovat L. Esophageal neoplasia arising from subsquamous buried glands after an apparently successful photodynamic therapy or radiofrequency ablation for Barrett’s associated neoplasia. Scand. J. Gastroenterol. 2015: 50 1315–1321.
6. Ross-Innes C.S. Debiram-Beecham I. Donovan M.O. Walker E. Varghese S. Lao-Sirieix P. Lovat L. Griffin M. Ragunath K. Haidry R. Sami S.S. Kaye P. Novelli M. Disep B. Ostler R. Aigret B. North B. V Bhandari P. Haycock A. 2015. Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett ’ s Esophagus : A Multi-Center Case – Control Study. PLoS One 2015: 3 1–19.
7. Haidry R.J. Butt M.A. Dunn J.M. Gupta A. Lipman G. Smart H.L. Bhandari P. Smith L. Willert R. Fullarton G. Pietro M. Di Gordon C. Penman I. Barr H. Patel P. Kapoor N. Hoare J. Narayanasamy R. Ang Y. Veitch A. Ragunath K. Novelli M. Lovat L.B. UK RFA Registry. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia : 6-year experience from the fi rst 500 patients treated in the UK patient registry. Gut 2015:64 1192–1199.

2014

1. Weaver J.M.J. Ross-innes C.S. Shannon N. Lynch A.G. Forshew T. Barbera M. Murtaza M. Ong C.J. Lao-sirieix P. Dunning M.J. Smith L. Smith M.L. Anderson C.L. Carvalho B. Donovan M.O. Underwood T.J. May A.P. Grehan N. Hardwick R. Davies J. Oloumi A. Aparicio S. Caldas C. Eldridge M.D. Edwards P.A.W. Rosenfeld N. Tavaré S. Fitzgerald R.C. Yeng A. Lydon A-M. Dharmaprasad S. Greer S. Preston S. Oakes S. Save V. Paterson-Brown S. Tucker O. Alderson D. Taniere P. Kelly J. Byrne J. Sharland D. Holling N. Boulter L. Noble F. Stacey B. Crichton C. Barr H. Shepherd N. Almond LM. Old O. Lagergren J. Gossage J. Davies A. Mason R. Chang F. Zylstra J. Sanders G. Wheatley T. Berrisford R. Bracey T. Harden C. Bunting D. Roques T. Nobes J. Loo S. Lewis M. Cheong E. Priest O. Parsons SL. Soomro I. Kaye P. Saunders J. Pang V. Welch NT. Catton J.A. Duffy J.P. Ragunath K. Lovat L. Haidry R. Miah H. Kerr S. Eneh V. Butawan R. Igali L. Ford H. Gilligan D. Safranek P. Hindmarsh A. Sudjendran V. Metz A. Carroll N. Scott M. Cluroe A. Miremadi A. Mahler-Araujo B. Knight O. Nutzinger B. Peters C. Abdullahi Z. Debriram-Beecham I. Malhotra S. Crawte J. MacRae S. Noorani A. Elliott RF. Li X. Bower L. Achilleos A. Bornschein J. Zeki S. Chettouh H. Secrier M. de Silva N. Gregson E. Yang T-P. O’Neil JR.. Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nature Genet.2014: 46 837–843.
2. Kumar S. Huang J. Abbassi-Ghadi N. Mackenzie H.A. Veselkov KA. Hoare JM. Lovat LB. Španěl P. Smith D. Hanna GB. 2015. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma. Annals of Surgery 262 981–990.
3. Zeki S.S. Haidry R. Justo-Rodriguez M. Lovat L.B. Wright N.A. Zeki S.S. Wright N.A. Mcdonald S.A. 2014. Squamous cell carcinoma after radiofrequency ablation for Barrett ’s dysplasia. World J Gastroenterol 20 4453–4456.
4. Liu X. Wong A. Kadri S.R. Corovic A. Donovan M.O. Lao- P. Lovat L.B. Burnham R.W. Fitzgerald R.C. Gastro-Esophageal Reflux Disease Symptoms and Demographic Factors as a Pre-Screening Tool for Barrett ’ s Esophagus. PLoS One 2014: 9 1–8
5. Rosenfeld A. Sehgal V. Graham D.G. Banks M.R. Haidry R.J. Lovat L.B. 2014. Using Data Mining to Help Detect Dysplasia: Extended Abstract. IEEE 65–66.

2013

Dunn, J. M., Mackenzie, G. D., Banks, M. R., Mosse, C. A., Haidry, R., Green, S., . . . Lovat, L. B. (2013). A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett’s oesophagus. Lasers Med Sci, 28 (3), 707-715. doi:10.1007/s10103-012-1132-1

Butt, M. A., Oukrif, D., Haidry, R. J., Rashid, M., Khan, S. . U. . R., Pye, H., . . . Lovat, L. B. (2013). CHARACTERISATION OF OESOPHAGEAL MUC1 EXPRESSION IN THE PROGRESSION TO OESOPHAGEAL ADENOCARCINOMA. GUT, 62, A113-A114. doi:10.1136/gutjnl-2013-304907.249

Paterson, A. L., Fitzgerald, R. C., O’Donovan, M., Provenzano, E., Murray, L. J., Coleman, H. G., . . . Lovat, L. B. (2013).Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis. Journal of Pathology, 230 (1), 118-128. doi:10.1002/path.4044

Zeki, S. S., Wright, N. A., McDonald, S. A. C., Haidry, R., Lovat, L. B., Graham, T. A., . . . Dunn, J. (2013). Clonal selection and persistence in dysplastic Barrett’s esophagus and intramucosal cancers after failed radiofrequency ablation. American Journal of Gastroenterology, 108 (10), 1584-1592. doi:10.1038/ajg.2013.238

Oukrif, D., Butt, M. A., Bloom, E. S., Haidry, R. J., Khan, S. . U. . R., Louis-Auguste, J., . . . Lovat, L. B. (2013). DNA PLOIDY ABNORMALITIES CORRELATE WITH INCREASING DEGREE OF DYSPLASIA IN CASES REFERRED TO A SPECIALIST CLINICAL IMAGE CYTOMETRY SERVICE FOR THE MANAGEMENT OF BARRETT’S OESOPHAGUS. GUT, 62, A113. doi:10.1136/gutjnl-2013-304907.248

Haidry, R. J., Butt, M., Louis-Auguste, J., Novelli, M., Lovat, L., & Banks, M. (2013). ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC NEOPLASIA; PROSPECTIVE OUTCOMES FROM A SINGLE TERTIARY CENTRE. GUT, 62, A228-A229. doi:10.1136/gutjnl-2013-304907.532

Butt, M. A., Haidry, R. J., Oukrif, D., Dunn, J., Bloom, E. S., Louis-Auguste, J., . . . Novelli, M. (2013). EXPRESSION OF POLO-LIKE KINASE 1 AND GEMININ IS UP-REGULATED IN THE SQUAMOUS-METAPLASIA-DYSPLASIA-CARCINOMA SEQUENCE AND CORRELATES WITH ANEUPLOIDY. GUT, 62, A114. doi:10.1136/gutjnl-2013-304907.251

Butt, M. A., Gandy, M., Haidry, R. J., Bloom, E. S., Mackie, S., Khan, M. S., . . . Novelli, M. (2013). HER2 POSITIVITY IN UPPER GASTROINTESTINAL TUMOURS IN A LARGE MULTI-CENTRE UK COHORT IDENTIFIES SIMILAR POSITIVITY RATES BUT DIFFERENT TRENDS THAN PREVIOUSLY REPORTED AND SUGGESTS NEW POTENTIAL AVENUES FOR HER2 THERAPIES. GUT, 62, A112-A113. doi:10.1136/gutjnl-2013-304907.247

Butt, M. A., De Sordi, L., Yahioglu, G., Moose, C., Battah, S., Stamati, I., . . . Lovat, L. B. (2013). PHOTODYNAMIC ANTIMICROBIAL CHEMOTHERAPY (PACT) SELECTIVELY KILLS CLOSTRIDIUM DIFFICILE OVER COLON CELLS AND IS EFFECTIVE AGAINST 5 HYPERVIRULENT STRAINS OF THE PATHOGEN. GUT, 62, A215. doi:10.1136/gutjnl-2013-304907.496

Haidry, R. J., Dunn, J. M., Butt, M. A., Burnell, M. G., Gupta, A., Green, S., . . . Lovat, L. B. (2013). Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett’s esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology, 145(1), 87-95. doi:10.1053/j.gastro.2013.03.045

Haidry, R. J., Butt, M. A., Dunn, J., Banks, M., Gupta, A., Smart, H., . . . Lovat, L. B. (2013). Radiofrequency ablation for early oesophageal squamous neoplasia: Outcomes form United Kingdom registry. World J Gastroenterol, 19 (36), 6011-6019. doi:10.3748/wjg.v19.i36.6011

Butt, M. A., Bloom, E. S., Stamati, I., Haidry, R. J., Oukrif, D., Khan, S. . U. . R., . . . Lovat, L. B. (2013). SECOND GENERATION PHOTOSENSITISER BASED PHOTODYNAMIC THERAPY IS EFFICACIOUS AND PENETRATES TISSUE MORE DEEPLY THAN RADIOFREQUENCY AND CRYO- ABLATIVE THERAPIES, OFFERING POTENTIAL FOR MORE INVASIVE GASTROINTESTINAL CANCERS. GUT, 62, A114. doi:10.1136/gutjnl-2013-304907.250

Butt, M. A., De Sordi, L., Yahioglu, G., Moose, C., Battah, S., Stamati, I., . . . Lovat, L. B. (2013). TWO PHASE PHOTODYNAMIC ANTIMICROBIAL CHEMOTHERAPY (PACT) COMBINED WITH GERMINANT THERAPY EFFECTIVELY TREATS CLOSTRIDIUM DIFFICILE AND THEIR SPORES THAT ARE RESISTANT TO ANTIBIOTICS. GUT, 62, A214-A215. doi:10.1136/gutjnl-2013-304907.495

Dunn, J. M., Mackenzie, G. D., Banks, M. R., Mosse, C. A., Haidry, R., Green, S., . . . Lovat, L. B. (2013). A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett’s oesophagus. Lasers Med Sci, 28 (3), 707-715. doi:10.1007/s10103-012-1132-1

Paterson, A. L., O’Donovan, M., Provenzano, E., Murray, L. J., Coleman, H. G., Johnson, B. T., . . . Fitzgerald, R. C. (2013). Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis. Journal of Pathology, 230 (1), 118-128.

Haidry, R. J., Dunn, J. M., Butt, M. A., Burnell, M. G., Gupta, A., Green, S., . . . Lovat, L. B. (2013). Radiofrequency Ablation and Endoscopic Mucosal Resection for Dysplastic Barrett’s Esophagus and Early Esophageal Adenocarcinoma: Outcomes of the UK National Halo RFA Registry. Gastroenterology, 145 (1), 87-95. doi:10.1053/j.gastro.2013.03.045

2012

Butt, M. A., Pye, H., Haidry, R. J., Oukrif, D., Rashid, M., Banks, M. R., . . . Lovat, L. B. (2012). ABERRANTLY GLYCOSYLATED MUC1 AS A POTENTIAL THERAPEUTIC TARGET FOR BARRETT’S WITH HIGH GRADE DYSPLASIA AND PRIMARY AND METASTATIC OESOPHAGEAL ADENOCARCINOMA. GUT, 61, A301. doi:10.1136/gutjnl-2012-302514d.11

Bennett, C., Vakil, N., Bergman, J., Harrison, R., Odze, R., Vieth, M., . . . Jankowski, J. A. (2012). Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology, 143 (2), 336-346. doi:10.1053/j.gastro.2012.04.032

Haidry, R. J., Dunn, J., Banks, M., Gupta, A., Butt, M. A., Smart, H., . . . Lovat, L. B. (2012). HALO RADIOFREQUENCY ABLATION FOR HIGH GRADE DYSPLASIA AND EARLY MUCOSAL NEOPLASIA ARISING IN BARRETT’S OESOPHAGUS: INTERIM RESULTS FORM THE UK HALO RADIOFREQUENCY ABLATION REGISTRY. GUT, 61, A308. doi:10.1136/gutjnl-2012-302514d.28

Butt, M. A., Haidry, R. J., Oukrif, D., Pye, H., Stamati, I., Yahioglu, G., . . . Lovat, L. B. (2012). HER2 EXPRESSION IN THE BARRETT’S METAPLASIA-DYSPLASIA-CARCINOMA SEQUENCE AND POTENTIAL TARGETING IN VITRO WITH THE SINGLE CHAIN ANTIBODY FRAGMENT C6.5. GUT, 61, A302-A303. doi:10.1136/gutjnl-2012-302514d.15

Butt, M. A., Pye, H., Stamati, I., Yahioglu, G., Haidry, R. J., Oukrif, D., . . . Lovat, L. B. (2012). IN VITRO CHARACTERISATION OF ABERRANTLY GLYCOSYLATED MUC1 BINDING-PS1 PHOTOIMMUNOCONJUGATES FOR OESOPHAGEAL ADENOCARCINOMA TARGETED PHOTODYNAMIC THERAPY IN PRIMARY AND METASTATIC DISEASE. GUT, 61, A301. doi:10.1136/gutjnl-2012-302514d.12

Haidry, R. J., Lovat, L. B., Banks, M., Gupta, A., Butt, M. A., Novelli, M., . . . Rich, P. (2012). INFRARED SPECTROSCOPY ACURATELY DETECTS BARRETT’S MUCOSA BIOPSY SPECIMENS EX VIVO. GUT, 61, A307. doi:10.1136/gutjnl-2012-302514d.26

Bird-Lieberman, E. L., Neves, A. A., Lao-Sirieix, P., O’Donovan, M., Novelli, M., Lovat, L. B., . . . Fitzgerald, R. C. (2012). Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett’s esophagus. Nat Med, 18 (2), 315-321. doi:10.1038/nm.2616

Wallace, M. B., Crook, J., Saunders, M. D., Lovat, L., Coron, E., Waxman, I., . . . Wolfsen, H. C. (2012). Multicenter, Randomized Controlled Trial of Confocal Laser Endomicroscopy Assessment of Residual Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia in Barrett’s Esophagus (Clean Margin Trial). GASTROINTESTINAL ENDOSCOPY, 75 (4), 174.

Wallace, M. B., Crook, J. E., Saunders, M., Lovat, L., Coron, E., Waxman, I., . . . Wolfsen, H. C. (2012). Multicenter, randomized, controlled trial of confocal laser endomicroscopy assessment of residual metaplasia after mucosal ablation or resection of GI neoplasia in Barrett’s esophagus. Gastrointestinal Endoscopy, 76 (3), 539-547e1.

Butt, M. A., Haidry, R. J., Oukrif, D., Dunn, J. M., Gupta, A., Bhatt, M., . . . Novelli, M. R. (2012). POLO-LIKE KINASE 1 EXPRESSION PREDICTS ANEUPLOIDY IN THE BARRETT’S METAPLASIA-DYSPLASIA-CARCINOMA SEQUENCE. GUT, 61, A302. doi:10.1136/gutjnl-2012-302514d.14

ird-Lieberman, E. L., Dunn, J. M., Coleman, H. G., Lao-Sirieix, P., Oukrif, D., Moore, C. E., . . . Fitzgerald, R. C. (2012). Population-based study reveals new risk-stratification biomarker panel for Barrett’s esophagus. Gastroenterology, 143 (4), 927-935.e3.

Allain, B., Hu, M., Lovat, L. B., Cook, R. J., Vercauteren, T., Ourselin, S., & Hawkes, D. J. (2012). Re-localisation of a biopsy site in endoscopic images and characterisation of its uncertainty. Med Image Anal, 16 (2), 482-496. doi:10.1016/j.media.2011.11.005

Butt, M. A., Stamati, I., Pye, H., Yahioglu, G., Haidry, R. J., Oukrif, D., . . . Lovat, L. B. (2012). SELECTIVE CYTOTOXICITY OF ABERRANTLY GLYCOSYLATED MUC1 BINDING-PS1 PHOTOIMMUNOCONJUGATES FOR OESOPHAGEAL ADENOCARCINOMA TARGETED PHOTODYNAMIC THERAPY IN PRIMARY AND METASTATIC DISEASE. GUT, 61, A302. doi:10.1136/gutjnl-2012-302514d.13

2011

Dunn, J. M., Mackenzie, G. D., Thorpe, S., Austwick, M., Mosse, C. A., Oukrif, D., . . . Lovat, L. B. (2011). A RANDOMISED CONTROLLED TRIAL OF ALA VERSUS PHOTOFRIN PDT FOR HIGH GRADE DYSPLASIA IN BARRETT’S OESOPHAGUS. GUT, 60, A172. B M J PUBLISHING GROUP. doi:10.1136/gut.2011.239301.365

Dunn, J. M., Mackenzie, G. D., Thorpe, S., Austwick, M., Mosse, C. A., Oukrif, D., . . . Lovat, L. (2011). A Randomised Controlled Trial of ALA V Photofrin PDT for High Grade Dysplasia in Barrett’s Esophagus. GASTROENTEROLOGY, 140 (5), S215-S216. W B SAUNDERS CO-ELSEVIER INC.

Sellaturay, P., Haidry, R., Dunn, J., Green, S., Rodriguez-Justo, M., Winstanley, A., . . . Lovat, L. (2011). APPROPRIATE STAGING RENDERS ABLATIVE THERAPY SAFE FOR HIGH GRADE DYSPLASIA IN BARRETT’S OESOPHAGUS. GUT, 60. B M J PUBLISHING GROUP. doi:10.1136/gut.2011.239301.424

Haidry, R., Butt, M. A., & Lovat, L. B. (2011). Advances in diagnostic endoscopy. Medicine, 39 (5), 279-283.

Dunn, J. M., Hveem, T., Pretorius, M., Oukrif, D., Nielsen, B., Albregtsen, F., . . . Danielsen, H. E. (2011). Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett’s oesophagus. Br J Cancer, 105 (8), 1218-1223. doi:10.1038/bjc.2011.353

Banks, M. R., Haidry, R., Butt, M. A., Whitley, L., Stein, J., Langmead, L., . . . Lovat, L. B. (2011). High resolution colonoscopy in a bowel cancer screening program improves polyp detection. World J Gastroenterol, 17 (38), 4308-4313. doi:10.3748/wjg.v17.i38.4308

Dunn, J. M., Bird-Lieberman, E. L., Coleman, H. G., Oukrif, D., Arthur, K., Lao-Sirieix, P., . . . NIBR Study Grp. (2011). IMAGE CYTOMETRY DNA PLOIDY ABNORMALITIES ARE AN INDEPENDENT RISK FACTOR FOR CANCER PROGRESSION IN NON-DYSPLASTIC BARRETT’S OESOPHAGUS AND LOW GRADE DYSPLASIA: RESULTS OF THE NIBR STUDY. GUT, 60. B M J PUBLISHING GROUP.doi:10.1136/gut.2011.239301.367

Bird-Lieberman, E. L., Neves, A. A., Lao-Sirieix, P., O’Donovan, M., Lovat, L. B., Mahal, L. K., . . . Fitzgerald, R. C. (2011). MOLECULAR IMAGING VIA NOVEL APPLICATION OF FLUORESCENT LECTINS PERMITS RAPID ENDOSCOPIC IDENTIFICATION OF DYSPLASIA IN BARRETT’S OESOPHAGUS. GUT, 60, A170. B M J PUBLISHING GROUP. doi:10.1136/gut.2011.239301.361

Bird-Liebeman, E. L., Neves, A. A., Lao-Sirieix, P., O’Donovan, M., Novelli, M., Lovat, L., . . . Fitzgerald, R. (2011). Molecular Imaging via Novel Application of Fluorescent Lectins Permits Rapid Endoscopic Identification of Dysplasia in Barrett’s Esophagus. GASTROENTEROLOGY, 140 (5), S752. W B SAUNDERS CO-ELSEVIER INC.

AUSTWICK, M., Woodhams, J. H., Chalau, V., Mosse, C. A., Eliot, C., Lovat, L. B., . . . Bown, S. G. (2011). Optical Pharmacokinetics measurements of photosensitizer concentrations in vivo. Journal of Innovative Optical Health Sciences, 4 (2), 97-111. doi:10.1142/S1793545811001460

Austwick, M. R., Woodhams, J. H., Chalau, V., Mosse, C. A., Eliot, C., Lovat, L., . . . Bown, S. G. (2011). Optical measurement of photosensitizer concentration in vivo. Journal of Innovative Optical Health Sciences, 4 (2), 97-111.

Bird-Lieberman, E. L., Dunn, J. M., Lao-Sirieix, P., Mullholland, H. G., Moore, C. E., Arthur, K., . . . Fitzgerald, R. C. (2011). PHASE 2 AND PHASE 3 MULTICENTRE STUDIES DEMONSTRATE THE POTENTIAL FOR GLYCANS AS PREDICTIVE BIOMARKERS IN BARRETT’S OESOPHAGUS. GUT, 60. B M J PUBLISHING GROUP. doi:10.1136/gut.2011.239301.360

Dunn, J. M., McDonald, S. A., Oukrif, D., Haidry, R. J., Butt, M. A., Lovat, E., . . . Novelli, M. R. (2011). PLK-1 IS UPREGULATED IN BARRETT’S ADENOCARCINOMA AND IS A SURROGATE MARKER OF ANEUPLOIDY. GUT, 60. B M J PUBLISHING GROUP. doi:10.1136/gut.2011.239301.366

Banks, M., Haidry, R., Whitley, L., Stein, J., Langmead, L., Bloom, S., . . . Lovat, L. (2011). POLYP DETECTION IS IMPROVED BY MEGAPIXEL WHITE LIGHT HIGH RESOLUTION COLONOSCOPY IN THE UK NATIONAL BOWEL CANCER SCREENING PROGRAM. GUT, 60, A190. B M J PUBLISHING GROUP. doi:10.1136/gut.2011.239301.402

Dunn, J. M., Bird-Lieberman, E. L., Lao-Sirieix, P., Mulholland, H. G., Oukrif, D., Walker, E. C., . . . Fitzgerald, R. (2011). Phase 3 Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett’s Esophagus. GASTROENTEROLOGY, 140 (5), S136. W B SAUNDERS CO-ELSEVIER INC.

Huggett, M. T., Baddeley, R. N. B., Sandanayake, N. S., Webster, G. J. M., Bown, S. G., Lovat, L. B., . . . Pereira, S. P. (2011). Photodynamic therapy of pancreatic cancer and elastic scattering spectroscopy of the duodenal mucosa for the detection of pancreaticobiliary malignancy. OPTICAL METHODS FOR TUMOR TREATMENT AND DETECTION: MECHANISMS AND TECHNIQUES IN PHOTODYNAMIC THERAPY XX, 7886. doi:10.1117/12.874053

Huggett, M. T., Baddeley, R. N. B., Sandanayake, N. S., Webster, G. J. M., Bown, S. G., Lovat, L. B., . . . Pereira, S. P. (2011). Photodynamic therapy of pancreatic cancer and elastic scattering spectroscopy of the duodenal mucosa for the detection of pancreaticobiliary malignancy. Progress in Biomedical Optics and Imaging – Proceedings of SPIE, 7886.

Dunn, J. M., McDonald, S. A., Oukrif, D., Haidry, R. J., Butt, M. A., Lovat, L., . . . Novelli, M. (2011). Plk-1 is Upregulated in Barrett’s Adenocarcinoma and is a Surrogate Marker of Aneuploidy. GASTROENTEROLOGY, 140 (5), S667. W B SAUNDERS CO-ELSEVIER INC.

Banks, M. R., Haidry, R. J., Whitley, L., Stein, J., Langrnead, L., Bloom, S. L., . . . Lovat, L. B. (2011). Polyp Detection is Improved by Megapixel White Light High Resolution Colonoscopy in the UK National Bowel Cancer Screening Program. GASTROENTEROLOGY, 140 (5), S559. W B SAUNDERS CO-ELSEVIER INC.

Haidry, R. J., Dunn, J. U., Thorpe, S., Fullarton, G., Smart, H., Bhandari, P., . . . Lovat, L. B. (2011). Radio Frequency Ablation is More Effective in Shorter Segments of Barrett’s Oesophagus for Eradication of High Grade Dysplasia/Intramucosal Cancer – Results From the UK RFA HALO Registry. GASTROENTEROLOGY, 140 (5), S215. W B SAUNDERS CO-ELSEVIER INC.

Dunn, J. M., Banks, M. R., Oukrif, D., Mackenzie, G. D., Thorpe, S., Rodriguez-Justo, M., . . . Lovat, L. B. (2011). Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett’s esophagus after failed photodynamic therapy. Endoscopy, 43 (7),627-630. doi:10.1055/s-0030-1256443

Allain, B., Hu, M., Lovat, L. B., Cook, R. J., Vercautran, T., Ourselin, S., & Hawkes, D. J. (2011). Re-localisation of a Biopsy Site in Endoscopic Images and Characterisation of its Uncertainty. Medical Image Analysis.

2010

Allain, B., Hu, M., Lovat, L. B., Cook, R. J., Vercauteren, T., Ourselin, S., & Hawkes, D. J. (2010). A system for biopsy site re-targeting with uncertainty in gastroenterology and oropharyngeal examinations. Med Image Comput Comput Assist Interv, 13 (Pt 2),514-521.

Dunn, J. M., Lovat, L. B., Pretorius, M. E., Oukrif, D., Hveem, T., Nielsen, B., . . . Danielsen, H. E. (2010). COMBINATION OF NUCLEAR TEXTURAL ANALYSIS AND IMAGE CYTOMETRIC DNA ANALYSIS IS MORE ACCURATE THAN IMAGE CYTOMETRIC DNA PLOIDY ANALYSIS ALONE FOR RISK STRATIFICATION IN BARRETT’S OESOPHAGUS. GUT, 59, A114-A115. B M J PUBLISHING GROUP. doi:10.1136/gut.2009.208983r

Dunn, J. M., Jiao, Y., Austwick, M., Mosse, C. A., Oukrif, D., Thorpe, S., . . . Lovat, L. B. (2010). ELASTIC SCATTERING SPECTROSCOPY IS HIGHLY ACCURATE FOR THE DETECTION OF HIGH-GRADE DYSPLASIA AND DNA PLOIDY ARISING IN BARRETT’S OESOPHAGUS USING A RED ENHANCED SPECTROMETER. GUT, 59, A115-A116. B M J PUBLISHING GROUP. doi:10.1136/gut.2009.208983t

Dunn, J. M., Thorpe, S., Fullarton, G. M., Smart, H., Penman, I., Patel, P., . . . Lovat, L. B. (2010). ENDOSCOPIC RADIOFREQUENCY ABLATION FOR HIGH-GRADE DYSPLASIA OR INTRAMUCOSAL CANCER IN BARRETT’S OESOPHAGUS – RESULTS FROM THE FIRST 100 PATIENTS ENROLLED IN THE UK HALO RADIOFREQUENCY ABLATION REGISTRY. GUT, 59, A115. B M J PUBLISHING GROUP. doi:10.1136/gut.2009.208983s

Dunn, J. M., Thorpe, S., Fullarton, G. M., Smart, H., Penman, I. D., Patel, P., . . . Lovat, L. (2010). Endoscopic Radiofrequency Ablation for HGD or IMC in Barrett’s Esophagus – Results From the First 100 Patients Enrolled in the UK RFA Registry. GASTROINTESTINAL ENDOSCOPY, 71 (5), AB176. MOSBY-ELSEVIER.

Dunn, J. M., Mackenzie, G. D., Oukrif, D., Mosse, C. A., Banks, M. R., Thorpe, S., . . . Lovat, L. B. (2010). Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett’s oesophagus following photodynamic therapy. Br J Cancer, 102 (11), 1608-1617. doi:10.1038/sj.bjc.6605688

Gupta, A., Dunn, J. M., Thorpe, S. M., Banks, M. R., Bown, S. G., & Lovat, L. B. (2010). PATTERN DISTRIBUTION OF BARRETT’S OESOPHAGUS BASED ON TWO-DIMENSIONAL RECONSTRUCTION OF MACROSCOPIC FINDINGS AT ENDOSCOPY. GUT, 59, A116. B M J PUBLISHING GROUP. doi:10.1136/gut.2009.208983u

Dunn, J., & Lovat, L. (2010). The role of endoscopic ultrasonography in Barrett’s esophagus and early esophageal cancer. Techniques in Gastrointestinal Endoscopy, 12 (1), 12-17.

2009

Allain,B., Hu,M., Lovat,L., Cook,R., Ourselin,S., Hawkes,D. (2009). Relocalisation method for an accurate matching of optical and histological biopsy sites in Barrett’s oesophagus. Gut 58, A508. ISSN: 0017-5749

Allain,B., Hu,M.X., Lovat,L.B., Ourselin,S., Cook,R., Hawkes,D.J. (2009). Biopsy Site Re-localisation based on the Computation of Epipolar Lines from Two Previous Endoscopic Images. MICCAI, Yang,G.Z., Hawkes,D.J., Rueckert,D. (ed.) Heidelberg:Springer, 5761, 491-498

Bown, Stephen G., Mackenzie, Gary D., Dunn, Jason M., Thorpe, Sally M., Lovat, Laurence B. (2009). ALA PDT for high grade dysplasia in Barrett’s oesophagus: review of a decade’s experience, Kessel, David H. (ed.) Seattle, WA, USA:SPIE, 7380 (1), 738018-738019 [Online]

Dunn,J.M., Fullarton,G., Thorpe,S.M., Novelli,M.R., Bown,S.G., Lovat,L. (2009). Radiofrequency ablation of high grade dysplasia in Barrett’s oesophagus after failed photodynamic therapy – results of the UK HALO RFA registry after one year. Gut 58, A48. ISSN: 0017-5749

Dunn,J.M., Thorpe,S., Novelli,M.R., Bown,S.G., Lovat,L.B. (2009). Initial results of radiofrequency ablation for the treatement of squamous high grade dysplasia of the oesophagus. Gut 58, A287. ISSN: 0017-5749

Dunn,J.M., Fullarton,G., Thorpe,S., Novelli,M., Bown,S.G., Lovat,L.B. (2009). RADIOFREQUENCY ABLATION OF HIGH-GRADE DYSPLASIA IN BARRETT’S OESOPHAGUS AFTER FAILED PHOTODYNAMIC THERAPY: FIRST RESULTS OF THE UK HALO RADIOFREQUENCY ABLATION REGISTRY. Gut 58, PT286. ISSN: 0017-5749

Dunn,J.M., Fullarton,G.M., Thorpe,S., Novelli,M., Bown,S.G., Lovat,L.B. (2009). Radiofrequency Ablation of High Grade Dysplasia in Barrett’s Oesophagus Is Safe and Effective After Failed Photodynamic Therapy – First Results of the UK HALO RFA Registry. Gastrointestinal Endoscopy 69(5), AB260. ISSN: 0016-5107

Dunn,J.M., Mackenzie,G.D., Oukrif,D., Mosse,C.A., Green,S., Chew,Y., Thorpe,S., Novelli,M., Bown,S.G., Lovat,L.B. (2009). DNA PLOIDY AS A PROGNOSTIC BIOMARKER AFTER AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY FOR HIGH-GRADE DYSPLASIA IN BARRETT’S OESOPHAGUS. Gut 58, PT285. ISSN: 0017-5749

Dunn,J.M., Thorpe,S., Novelli,M., Bown,S.G., Lovat,L.B. (2009). Radiofrequency Ablation for the Treatment of Squamous High Grade Dysplasia of the Oesophagus- First Reported Series. Gastrointestinal Endoscopy 69(5), AB255. ISSN: 0016-5107

Mackenzie,G.D., Dunn,J.M., Selvasekar,C.R., Mosse,C.A., Thorpe,S.M., Novelli,M.R., Bown,S.G., Lovat,L.B. (2009). Optimal conditions for successful ablation of high-grade dysplasia in Barrett’s oesophagus using aminolaevulinic acid photodynamic therapy. Lasers in Medical Science 24(5), 729-734. ISSN: 0268-8921

Paterson,A.L., Provenzano,E.,O’Donovan,M., Davies,S.E., Novelli,M.R., Lovat,L.B., Fitzgerald,R.C. (2009). ERBB2 EXPRESSION IN OESOPHAGEAL ADENOCARCINOMA AND BARRETT’S OESOPHAGUS: DEMONSTRATING THE POTENTIAL FOR A PRE-EMPTIVE STRIKE. Gut 58, PT283. ISSN: 0017-5749 S

ilvanto,A., Novelli,M., Lovat,L.B. (2009). SIRT – an uncommon cause of gastroduodenal ulceration. Histopathology 55(1), 114-115. ISSN: 0309-0167

Thorpe,S., Dunn,J.M., Mackenzie,G.D., Mosse,C.A., Austwick,M., Bown,S.G., Lovat,L.B. (2009). Quality of life following ALA v Photofrin PDT for dysplastic Barrett’s oesophagus – preliminary results of a randomised controlled trial. Gut 58, A133. ISSN: 0017-5749

Zhu,Y., Fearn,T., Mackenzie,G., Clark,B., Dunn,J.M., Bigio,I.J., Bown,S.G., Lovat,L.B. (2009). Elastic scattering spectroscopy for detection of cancer risk in Barrett’s esophagus: experimental and clinical validation of error removal by orthogonal subtraction for increasing accuracy. Journal of Biomedical Optics 14(4), 044022. ISSN: 1083-3668

• 1986: University of London AH Bygott Undergraduate Award in Community Medicine
• 1986: International Foundation for Promotion of Nutrition Research and Nutrition Education Student Award (£1,200)
• 1987: British Nutrition Foundation Student Award
• 1987: Riker Laboratories Student Elective Prize
• 1991: British Geriatric Society Senior Registrar Research Start Up Grant (£1,500)
• 1994 Hammersmith SHA Research Grant (£9,500)
• 2000: AstraZeneca Effect of Gastro-Oesophageal Reflux Treatment and Arousals in Patients with Obstructive Sleep Apnoea (£6,500)
• 2000-2002: Association for International Cancer Research Photodynamic Therapy for the Treatment of Barrett’s oesophagus (£114,000)
• 2002-2004: DUSA Pharmaceuticals Inc Randomised controlled trial of Photodynamic Therapy for High Grade Dysplasia in Barrett’s oesophagus (£101,000)
• 2002-2004: National Translational Cancer Research Network (NTRAC). The role of cytokines in oesophageal mucosal repair following photodynamic therapy for Barrett’s oesophagus (£20,000)
• 2003-2004: UCL Clinical Research and Development Committee (CRDC) Fast Track Grant: Elastic scattering spectroscopy as in vivo test for aneuploidy in Barrett’s oesophagus (£25,000)
• 2004-2009: NIH – National Cancer Institute Network for Translational Research into Optical Imaging: Elastic scattering spectroscopy in the management of Barrett’s oesophagus – detection of dysplasia and monitoring of photodynamic therapy. ($545,000, £328,970)
• 2005-2006: NIH – National Cancer Institute Network for Translational Research into Optical Imaging Development Grant: Elastic Scattering Spectroscopy to Detect Molecular Markers of Malignant Progression in Barrett’s oesophagus: Methods to Rapidly Prove the Principle (£36,790)
• 2005-2007: Axcan Pharmaceuticals – Trial of Allopurinol to reduce skin phototoxicity after photodynamic therapy with Photofrin (£78,000)
• 2007-2012: CRUK – Experimental Cancer Medicine Programme Grant £1,176,675: PI (29 Co-investigators).
• 2008-2011: MRC – Biomarker qualification in Barrett’s oesophagus. MRC Grant G0601390 (Total £1,061,564, MRC contribution £436,677). PI. Lead applicant: Dr R Fitzgerald, Cambridge, Coapplicants: Prof L Murray, Belfast, Prof K Brindle, Dr B Johnston, Dr D McManus, Prof M Novelli, Dr C Patterson
• 2008-2011: CRUK – Project Grant: Elastic Scattering Spectroscopy for diagnosis of dysplasia and aneuploidy in Barrett’s oesophagus £325,710: CI. Sponsor Reference C18515/A9022
• 2008-2009: Given Imaging – Differentiation of squamous from columnar mucosa in the oesophagus using a reduced number of wavelengths £78,964
• 2009-2010: Barrett’s Oesophagus Campaign – Building a Research Database to support the National Barrett’s Dysplasia Audit £10,000: CI
• 2012-2017    CRUK: Experimental Cancer Medicine Programme Grant £2,495,356: Coapplicant.
• 2013-2014    MRC Technology Strategy Board: Biomedical Catalyst Fund: A theranostic approach to gastric cancer Total grant: £173,595, PI
• 2013-2015     MRC Technology Strategy Board: Biomedical Catalyst Fund: Antibody directed phototherapy for oesophageal adenocarcinoma Total grant: £645,665, PI
• 2013-2016  EPSRC: Endoscopic Photoacoustic Devices For Minimally Invasive Biomedical Sensing And Imaging £628,525: Co-I
• 2017-2022   Wellcome EPSRC Centre for Surgery & Interventional Science £13.1m, Clinical Director, Co-I
• 2017-2021   Core – The Digestive Disorders Foundation, Development Grant: Salivary EpigeNetics to Stratify Oesophageal cancer Risk (SENSOR) £124,387, CI
• 2017-2021   EPSRC: Improving the outcomes of oesophageal interventions through novel x-ray based imaging methods £ 1,136,998. Co-I
• 2019-2023  Leona and Harry Helmsley Charitable Trust SPIT-C: Using Saliva to PredIcT Crohn’s disease £929,627 CI
• 2019-2023           EU Horizon 2020: FET Open – Novel ideas for radically new technologies.  Endomapper: Real-time mapping from endoscopic video.  €3.7m (UCL portion €1.2m). Lead Prof Montiel, University of Zaragoza, Spain. Co-Investigator.
• 2019-2024           CRUK:  International Cancer Early Detection (ICED) Alliance: Optimising The Role Of Imaging In The Early Detection Of Cancer. £3m Co-Investigator
• 2020-2021           Bill and Melinda Gates Foundation: CROWN CORONATION: Chloroquine RepurpOsing to healthWorkers for Novel CORONAvirus mitigaTION  $9,000,000 (UCL portion £1,500,573). Lead Prof Michael Avidan, St Louis USA. UK Chief Investigator Lovat
• 2022-2024            Wellcome EPSRC Centre for Surgery & Interventional Science Renewal £4.6m, Clinical Director, Co-Investigator
• 2022-2024            Innovate UK: RESECT-AI: Reliable Estimations for Safer Endoscopic Cancer Therapy with Artificial Intelligence UCL portion £216,505 Co-Investigator. Lead Dr Daniel Toth, Odin Medical Ltd.
• 2023-2028            NIHR Patient Safety Research Collaboration £3,029m Co-Investigator (Prof Ramani Moonesinghe, UCL, lead)

Professor Lovat is a fee assured BUPA consultant. He is also part of the BUPA Premier Consultant Partnership. Patients insured with BUPA should never encounter any shortfalls in their fees.

Prof. Lovat likes to his patients to be comfortable that there will not be unexpected fees. He therefore tries to work within the published fee schedules of all the other major UK private healthcare insurance companies. You should know however that with the very wide variety of private insurance schemes on the market, you may have personal liabilities. This is particularly common with WPA patients who often agree to pay a proportion of all fees. Please always check with your insurance company. If you would like a formal quote, we are happy to provide these.

For patients without insurance, and for people who have taken out insurance with insurance companies outside the UK, please request a formal quotation. We will usually ask you to pay us directly and reclaim the fees from your insurer.

More than 90% of patients who took our survey are ‘Very’ or ‘Extremely’ likely to recommend Professor Lovat

88% of patients who took our survey say Professor Lovat listens very or extremely well

More than 90% of patients who took our survey say Professor Lovat’s staff are very or extremely friendly